Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics
Theravance Biopharma, Inc. - Ordinary Shares (TBPH)
Today's Latest Price: $25.11 USD
1.58 (-5.92%)
Updated May 27 4:00pm
Add TBPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
TBPH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for TBPH is -0.56 -- better than merely 6.36% of US stocks.
- TBPH's price/sales ratio is 19.15; that's higher than the P/S ratio of 93.08% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -2.78 for Theravance Biopharma Inc; that's greater than it is for just 4.06% of US stocks.
- If you're looking for stocks that are quantitatively similar to Theravance Biopharma Inc, a group of peers worth examining would be MXL, NVCN, LJPC, AGIO, and CLLS.
- TBPH's SEC filings can be seen here. And to visit Theravance Biopharma Inc's official web site, go to www.theravance.com.
TBPH Daily Price Range
TBPH 52-Week Price Range
TBPH Stock Price Chart More Charts
TBPH Price/Volume Stats
| Current price | $25.11 | 52-week high | $31.54 |
| Prev. close | $26.69 | 52-week low | $15.18 |
| Day low | $24.79 | Volume | 331,200 |
| Day high | $26.65 | Avg. volume | 392,252 |
| 50-day MA | $25.66 | Dividend yield | N/A |
| 200-day MA | $22.98 | Market Cap | 1.58B |
Theravance Biopharma, Inc. - Ordinary Shares (TBPH) Company Bio
Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company was founded in 2013 and is based in George Town, the Cayman Islands.
Loading social stream, please wait...